NEW YORK CITY, NY / ACCESS Newswire / February 24, 2026 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. ("Hims & Hers" or "the Company") (NYSE:HIMS). Investors who purchased Hims & Hers securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/HIMS.
Hims & Hers Investigation Details
Hims & Hers is the subject of a statement by the FDA in which the agency announced "its intent to take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies – including Hims & Hers and other compounding pharmacies – as similar alternatives to FDA-approved drugs." The Company is also the subject of a lawsuit filed by Novo Nordisk seeking to bar it from selling compounded weight loss drugs. Following this news, shares of Hims & Hers dropped over 17.8% on afternoon trading on February 9, 2026.
What’s Next for Hims & Hers Investors?
If you are aware of any facts relating to this investigation or purchased Hims & Hers securities, you can assist this investigation by visiting the firm’s site: bgandg.com/HIMS. You can also contact Peretz Bronstein or his client relations manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC: 917-590-0911
No Cost to Hims & Hers Investors
We, Bronstein, Gewirtz & Grossman, LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Hims & Hers Securities Investigation?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | info@bgandg.com
Attorney advertising.
Prior results do not guarantee similar outcomes.
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View the original press release on ACCESS Newswire
COMTEX_474149630/2457/2026-02-24T11:11:40